Literature DB >> 14573774

Selective interaction of ARF1 with the carboxy-terminal tail domain of the 5-HT2A receptor.

Derek N Robertson1, Melanie S Johnson, Louise O Moggach, Pamela J Holland, Eve M Lutz, Rory Mitchell.   

Abstract

The 5-hydroxytryptamine 2A receptor (5-HT2AR) is a member of the class I family of rhodopsin-related G protein-coupled receptors. The receptor is known to activate phospholipase C via the heterotrimeric G proteins Gq/11, but we showed previously that it can also signal through the phospholipase D (PLD) pathway in an ADP-ribosylation factor (ARF)-dependent manner that seems to be independent of Gq/11 (Mitchell et al., 1998). Both coimmunoprecipitation experiments and the effects of negative mutant ARF constructs on 5-HT2AR-induced PLD activation here suggested that ARF1 may play a greater role than ARF6 in the function of this receptor. Furthermore, we demonstrated using glutathione S-transferase (GST)-fusion proteins of receptor domains that ARF1 and ARF6 bind to the third intracellular loop (i3) and the carboxy terminal tail (ct) of the 5-HT2AR. The association of ARF1 with the ct domain of the receptor was stronger than its interaction with i3, or the interactions of ARF6 with either construct. Experiments using ARF mutants that are deficient in GTP loading, and the in vitro addition of GTPgammaS suggested that GTP loading enhances ARF1 binding to the receptor. The N376PxxY motif in the transmembrane 7 domain of the receptor (rather than a N376DPxxY mutant form) was shown to be essential for ARF-dependent PLD signaling and ARF1 coimmunoprecipitation. In GST-fusion proteins of the 5-HT2AR ct domain, mutation of Asn376 to Asp also markedly reduced ARF1-HA binding, although additional motifs in the Asn376-Asn384 sequence and to a lesser extent elsewhere, seem also to contribute to the interaction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573774     DOI: 10.1124/mol.64.5.1239

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  12 in total

1.  Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulation.

Authors:  Bryan L Roth
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

2.  Rhodopsin C terminus, the site of mutations causing retinal disease, regulates trafficking by binding to ADP-ribosylation factor 4 (ARF4).

Authors:  Dusanka Deretic; Andrew H Williams; Nancy Ransom; Valerie Morel; Paul A Hargrave; Anatol Arendt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

3.  Role of curcumin in PLD activation by Arf6-cytohesin1 signaling axis in U46619-stimulated pulmonary artery smooth muscle cells.

Authors:  Sajal Chakraborti; Jaganmay Sarkar; Rajabrata Bhuyan; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2017-08-05       Impact factor: 3.396

4.  Mono-ADP-ribosylation of the G protein betagamma dimer is modulated by hormones and inhibited by Arf6.

Authors:  Nadia Dani; Emilia Mayo; Annalisa Stilla; Adriano Marchegiani; Simone Di Paola; Daniela Corda; Maria Di Girolamo
Journal:  J Biol Chem       Date:  2010-12-09       Impact factor: 5.157

5.  Regulation of α(2B)-adrenergic receptor-mediated extracellular signal-regulated kinase 1/2 (ERK1/2) activation by ADP-ribosylation factor 1.

Authors:  Chunmin Dong; Chunman Li; Guangyu Wu
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

Review 6.  Communication between 5-HT and small GTPases.

Authors:  Charles P Mercado; Endrit Ziu; Fusun Kilic
Journal:  Curr Opin Pharmacol       Date:  2011-02-12       Impact factor: 5.547

Review 7.  Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.

Authors:  Leonard L Howell; Kathryn A Cunningham
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

8.  Role of G(q) protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.

Authors:  Efrain E Garcia; Randy L Smith; Elaine Sanders-Bush
Journal:  Neuropharmacology       Date:  2007-04-04       Impact factor: 5.250

9.  G-protein-coupled receptor interaction with small GTPases.

Authors:  Chunmin Dong; Guangyu Wu
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

Review 10.  Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.

Authors:  Juan F López-Giménez; Javier González-Maeso
Journal:  Curr Top Behav Neurosci       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.